Celldex Therapeutics (CLDX) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Celldex Therapeutics (CLDX) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 29.47% |
| 10 | Celldex Therapeutics | 2.34 Bn | 2.34 Bn | -1.44 Mn | -56.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.06% |
| Dec 31, 2025 | -6,152.09% |
| Sep 30, 2025 | -1,238.74% |
| Jun 30, 2025 | -255.16% |
| Mar 31, 2025 | -243.87% |
| Dec 31, 2024 | -37.62% |
| Sep 30, 2024 | -150.77% |
| Dec 31, 2023 | -17.25% |
| Dec 31, 2022 | -26.31% |
| Sep 30, 2022 | 23.13% |
| Jun 30, 2022 | 32.58% |
| Mar 31, 2022 | 45.47% |
| Dec 31, 2021 | -17.61% |
| Dec 31, 2020 | 4.12% |
| Dec 31, 2018 | 30.28% |
| Dec 31, 2017 | 13.21% |
| Dec 31, 2015 | 86.27% |
| Dec 31, 2014 | 82.65% |
| Dec 31, 2013 | -43.52% |
| Sep 30, 2013 | -29.57% |